In a Phase III clinical trial, a therapy known as Tumor Treating Fields (TTFields) increased survival for patients whose ...
The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback